Dry Cough Caused by E-Cigarettes: Expert Warnings

Industry Insight by 2FIRSTS.ai
Apr.29.2024
Dry Cough Caused by E-Cigarettes: Expert Warnings
Health experts warn of differences in coughing between e-cigarettes and traditional tobacco, with potential long-term health risks.

According to Russian media "Today Russia," health experts warn that the dry cough caused by e-cigarettes is different from the phlegm-producing cough caused by traditional tobacco. The usage instructions for e-cigarettes also clearly warn about this common phenomenon and specifically caution first-time e-cigarette users who have recently quit traditional tobacco.

 

Experts believe that this may be a sign of the body recovering from years of tobacco smoke. Smoking can damage tiny structures in the airways called cilia, which are designed to clear debris and mucus from the lungs. When irritants linger in the lungs, mucus builds up and the body attempts to clear the airways, leading to "smoker's cough.

 

Professor Leon Shahab, co-director of the Tobacco and Alcohol Research Group at University College London, stated: "Coughing caused by e-cigarettes is a natural response as the body recovers from tobacco use, during which the cilia in the lungs repair and regain functionality. Therefore, if smokers switch to e-cigarettes, similar symptoms may occur.

 

Peter Hajek, a renowned researcher and professor in the field of e-cigarettes at Queen Mary University of London, stated that "e-cigarette cough" typically disappears after a few weeks of use.

 

E-cigarettes allow users to inhale nicotine vapor, which is created by heating e-liquid that typically contains propylene glycol, glycerin, flavorings, and other chemicals. Unlike traditional tobacco, e-cigarettes do not contain tobacco and do not produce tar or carbon monoxide.

 

However, evidence of the potential risks of e-cigarettes is increasing. Multiple studies have raised concerns about the potential harm of e-cigarettes. Last month, an academic study sparked worries about the potential for e-cigarettes to cause cancer.

 

Doctors are concerned about potential lung diseases, dental issues, and even cancer that may arise in the future, affecting individuals who started using e-cigarettes at a young age.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.
Feb.10 by 2FIRSTS.ai
Japan Tobacco Expands Heated Tobacco Customization Strategy with Artist-Led Limited Editions
Japan Tobacco Expands Heated Tobacco Customization Strategy with Artist-Led Limited Editions
Japan Tobacco has launched a limited-edition Ploom AURA front panel series in collaboration with musician Ichiro Yamaguchi, featuring five customized designs incorporating brass, Kutani ware, verdigris, kintsugi, and rosewood motifs. Two editions are available through retail channels, while three are distributed via a membership lottery system. The initiative highlights JT’s growing focus on exterior customization and design partnerships as part of its broader heated tobacco brand strategy.
Feb.11 by 2FIRSTS.ai
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
BAT CEO Says 2026 Return to Growth Hinges on U.S. Enforcement, Highlights Oral Leadership
British American Tobacco said 2026 will mark a return to its mid-term growth algorithm, but CEO Tadeu Marroco stressed that deliverywill depend heavily on enforcement against illicit vapour products in the United States. Speaking at the FY2025 results call, he positioned Modern Oral as the company’s primary structural growth engine, reframed accelerating cigarette declines through “poly-usage,” and reinforced capital discipline with an expanded share buyback plan.
Feb.12
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
China Tobacco Hubei Industrial Co., Ltd. has published a patent describing a laboratory method to evaluate the reproductive and developmental safety of heated tobacco products using non-human animal exposure models. The approach introduces a structured toxicological testing framework that could support safety verification, quality control, and regulatory evidence generation for heated tobacco products.
Mar.09
China’s tobacco regulator names Yao Laiying as top leader
China’s tobacco regulator names Yao Laiying as top leader
China’s tobacco regulator has undergone a top leadership change, according to an official announcement on March 20.
Mar.20